Related Experiment Video
Updated: May 18, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Transcriptional regulation of the human tumor suppressor DOK1 by E2F1
Maha Siouda1, Jiping Yue, Ruchi Shukla
1International Agency for Research on Cancer, Lyon, France.
Abstract:
The expression of the tumor suppressor DOK1 is repressed in a variety of human tumors as a result of hypermethylation of its promoter region. However, the molecular mechanisms by which DOK1 expression is regulated have been poorly investigated. Here, we show that the expression of DOK1 is regulated mainly by the transcription factor E2F1. We identified three putative E2F1 response elements (EREs) in the DOK1 promoter region. E2F1 had a relatively higher binding affinity for the ERE located between bp -498 and -486 compared with the other two EREs. E2F1 gene silencing strongly inhibited DOK1 expression. E2F1-driven DOK1 transcription occurred in the presence of cellular stresses, such as accumulation of DNA damage induced by etoposide. DOK1 silencing promoted cell proliferation and protected against etoposide-induced apoptosis, indicating that DOK1 acts as a key mediator of cellular stress-induced cell death. Most importantly, we observed that DNA methylation of the DOK1 core promoter region found in head and neck cancer cell lines hampered the recruitment of E2F1 to the DOK1 promoter and compromised DOK1 expression. In summary, our data show that E2F1 is a key factor in DOK1 expression and provide novel insights into the regulation of these events in cancer cells.
Insights
The transcription factor E2F1 drives tumor suppressor DOK1 expression, which is silenced by DNA methylation in head and neck cancers. DOK1 mediates stress-induced cell death, and its regulation by E2F1 is crucial in cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- DOK1 tumor suppressor expression is reduced in cancers due to promoter hypermethylation.
- Mechanisms regulating DOK1 expression remain largely unknown.
Purpose of the Study:
- To elucidate the molecular mechanisms regulating DOK1 expression.
- To investigate the role of transcription factor E2F1 in DOK1 regulation.
- To understand DOK1's function in cellular stress and cancer.
Main Methods:
- Identification and analysis of E2F1 response elements (EREs) in the DOK1 promoter.
- E2F1 gene silencing experiments.
- Assessment of DOK1 expression under cellular stress (etoposide).
- Investigation of DNA methylation effects on E2F1 binding and DOK1 expression in cancer cell lines.
Main Results:
- E2F1 is a primary regulator of DOK1 expression, binding to specific EREs in its promoter.
- E2F1-dependent DOK1 transcription is induced by cellular stress and DNA damage.
- DOK1 silencing promotes proliferation and inhibits apoptosis, highlighting its role in cell death.
- DNA methylation in head and neck cancer cell lines impairs E2F1 recruitment and DOK1 expression.
Conclusions:
- E2F1 is a critical factor for DOK1 expression.
- Aberrant DNA methylation of the DOK1 promoter disrupts E2F1 binding, contributing to cancer progression.
- DOK1 acts as a mediator of stress-induced cell death, and its dysregulation impacts cancer cell fate.
Related Concept Videos
Abnormal Proliferation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Master Transcription Regulators
Negative Regulator Molecules
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epigenetic Regulation
X-chromosome...

